脂蛋白(a)对卒中复发的影响在低低密度脂蛋白胆固醇和炎症水平下减弱
这项前瞻性队列研究纳入9899例缺血性卒中或短暂性脑缺血发作患者,随访1年,评估在低密度脂蛋白胆固醇(LDL-C)和炎症水平维持较低时,脂蛋白(a)(Lp(a))的残余卒中风险是否仍然存在。结果显示,Lp(a)≥50 mg/dL患者卒中复发风险高于Lp(a)<50 mg/dL患者(11.5% vs 9.4%;调整HR 1.20 [95%CI 1.02-1.42]),但在LDL-Cc<55 mg/dL或IL-6<2.65 ng/L时该风险减弱。
要点
- Lp(a)≥50 mg/dL患者1年卒中复发风险高于Lp(a)<50 mg/dL患者(11.5% vs 9.4%;调整HR 1.20 [95%CI 1.02-1.42])。
- LDL-Cc<55 mg/dL时,高Lp(a)与低Lp(a)的复发率无显著差异(8.9% vs 9.0%;调整HR 0.92 [95%CI 0.65-1.30])。
- LDL-Cc、IL-6、hsCRP与Lp(a)水平对卒中复发风险无交互作用。
核心结论
- 在缺血性卒中/短暂性脑缺血发作患者中,Lp(a)升高与卒中复发风险显著相关。
- 在低LDL-Cc或低IL-6水平时,Lp(a)升高相关的卒中复发风险在二级预防设置中减弱。
研究设计与样本
- 前瞻性队列研究,纳入第三次中国国家卒中登记中9899例缺血性卒中或短暂性脑缺血发作患者,均有血浆Lp(a)测量并随访1年。
主要发现
- Lp(a)≥50 mg/dL患者卒中复发率11.5%,Lp(a)<50 mg/dL患者为9.4%,调整HR 1.20(95%CI 1.02-1.42)。
- LDL-Cc<55 mg/dL时,高Lp(a)与低Lp(a)患者复发率分别为8.9%和9.0%,调整HR 0.92(95%CI 0.65-1.30)。
- IL-6<2.65 ng/L时,高Lp(a)与低Lp(a)患者复发率分别为9.0%和7.8%,调整HR 1.14(95%CI 0.87-1.49)。
- LDL-Cc<55 mg/dL且IL-6<2.65 ng/L时,高Lp(a)与低Lp(a)患者复发率分别为6.2%和7.1%,调整HR 0.86(95%CI 0.46-1.62)。
- LDL-Cc<55 mg/dL且hsCRP<2 mg/L时,高Lp(a)与低Lp(a)患者复发率分别为7.7%和7.6%,调整HR 0.97(95%CI 0.57-1.66)。
关键数值与推荐
- Lp(a)切点为50 mg/dL。
- LDL-Cc切点为55 mg/dL和70 mg/dL。
- IL-6阈值取中位数2.65 ng/L。
- hsCRP阈值取中位数2 mg/L。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lp(a) (lipoprotein(a)) contributes to cardiovascular disease mainly through proatherogenic and proinflammatory effects. Here, we aimed to evaluate whether a residual stroke risk of Lp(a) would remain when the LDL-C (low-density lipoprotein cholesterol) and inflammatory levels are maintained low. METHODS: This prospective cohort study included 9899 patients with ischemic stroke or transient ischemic attack from the Third China National Stroke Registry who had measurements of plasma Lp(a) and were followed up for 1 year. Cutoffs were set at the 50 mg/dL for Lp(a). LDL-C was corrected for Lp(a)-derived cholesterol (LDL-Cc [LDL-C corrected]) and cutoffs were set at 55 and 70 mg/dL.The threshold values of IL-6 (interleukin 6) and hsCRP (high-sensitive C-reactive protein) were the median 2.65 ng/L and 2 mg/L. Multivariable-adjusted hazard ratio (HR) were calculated using Cox regression models for each category to investigate the associations of Lp(a) with stroke recurrence within 1 year. RESULTS: Among all patients, those with Lp(a) ≥50 mg/dL were at higher stroke recurrence risk than those with Lp(a) <50 mg/dL (11.5% versus 9.4%; adjusted HR, 1.20 [95% CI, 1.02-1.42]). However, the risk associated with elevated Lp(a) was attenuated in patients with LDL-Cc <55 mg/dL (high Lp(a) versus low Lp(a): 8.9% versus 9.0%; adjusted HR, 0.92 [95% CI, 0.65-1.30]) or IL-6 <2.65 ng/L (9.0% versus 7.8%; adjusted HR, 1.14 [95% CI, 0.87-1.49]). Notably, in the group with both low LDL-Cc and inflammation levels, the rate of patients with high Lp(a) did not significantly different from the rate of patients with low Lp(a; LDL-Cc <55 mg/dL and IL-6 <2.65 ng/L: 6.2% versus 7.1%; adjusted HR, 0.86 [95% CI, 0.46-1.62]; LDL-Cc <55 mg/dL and hsCRP <2 mg/L: 7.7% versus 7.6%; adjusted HR, 0.97 [95% CI, 0.57-1.66]). However, there was no interaction between the LDL-Cc, IL-6, hsCRP, and Lp(a) levels on stroke recurrence risk. CONCLUSIONS: Increased Lp(a) was significantly associated with stroke recurrence risk in patients with ischemic stroke/transient ischemic attack. However, at low LDL-Cc or IL-6 levels, the elevated Lp(a) -associated stroke recurrence risk was attenuated in a secondary prevention setting.
引用
- Xu J, Hao X, Zhan R, et al. Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels. Stroke. 2022. PMID: 35410491. doi:10.1161/STROKEAHA.121.034924
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。